Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Nguyen AnhCo
Atara Biotherapeutics | 3: Initial statement of beneficial ownership of securities-Director Adiumentum Capital Fund I LP
Atara Biotherapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adiumentum Capital Fund I LP(19.99%),Adiumentum Capital Fund I GP LLC(19.99%), etc.
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Touchon Pascal
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Henrich Jill
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hyllengren Eric J
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Murugan Amar
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Nguyen AnhCo
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Touchon Pascal
Atara Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(0.0%)
Atara Biotherapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Adiumentum Capital Fund I LP(6.7%),Adiumentum Capital Fund I GP LLC(6.7%), etc.
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Touchon Pascal
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Nguyen AnhCo
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Murugan Amar
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hyllengren Eric J
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Henrich Jill
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fust Matthew K
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director HEIDEN WILLIAM K
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Roncarolo Maria Grazia
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gallagher Carol Giltner
No Data